Suppr超能文献

Editorial: Precision/Personalized Pediatric Oncology and Immune Therapies: Rather Customize Than Randomize.

作者信息

Kýr Michal, Klement Giannoula Lakka, Zdrazilova-Dubska Lenka, Demlova Regina, Valik Dalibor, Slaby Ondrej, Slavc Irene, Sterba Jaroslav

机构信息

Department of Pediatric Oncology, University Hospital Brno, Brno, Czechia.

Faculty of Medicine, Masaryk University, Brno, Czechia.

出版信息

Front Oncol. 2020 Mar 24;10:377. doi: 10.3389/fonc.2020.00377. eCollection 2020.

Abstract
摘要

相似文献

1
Editorial: Precision/Personalized Pediatric Oncology and Immune Therapies: Rather Customize Than Randomize.
Front Oncol. 2020 Mar 24;10:377. doi: 10.3389/fonc.2020.00377. eCollection 2020.
3
N-of-1 Trials in Pediatric Oncology: From a Population-Based Approach to Personalized Medicine-A Review.
Cancers (Basel). 2021 Oct 29;13(21):5428. doi: 10.3390/cancers13215428.
4
Genomic Alteration-Driven Clinical Trial Designs in Oncology.
Ann Intern Med. 2016 Aug 16;165(4):270-8. doi: 10.7326/M15-2413. Epub 2016 May 24.
5
Precision medicine in pediatric oncology.
Curr Opin Pediatr. 2018 Feb;30(1):17-24. doi: 10.1097/MOP.0000000000000570.
6
Precision oncology: neither a silver bullet nor a dream.
Pharmacogenomics. 2017 Nov;18(16):1525-1539. doi: 10.2217/pgs-2017-0094. Epub 2017 Oct 24.
8
Editorial: Precision Medicine in Veterinary Oncology.
Front Vet Sci. 2021 Jul 14;8:718891. doi: 10.3389/fvets.2021.718891. eCollection 2021.
9
An appraisal of drug development timelines in the Era of precision oncology.
Oncotarget. 2016 Aug 16;7(33):53037-53046. doi: 10.18632/oncotarget.10588.
10
Individualized dosing of oral targeted therapies in oncology is crucial in the era of precision medicine.
Eur J Clin Pharmacol. 2019 Sep;75(9):1309-1318. doi: 10.1007/s00228-019-02704-2. Epub 2019 Jun 7.

引用本文的文献

1
The Application of Evidence-Based Medicine in Individualized Medicine.
Biomedicines. 2023 Jun 23;11(7):1793. doi: 10.3390/biomedicines11071793.
2
N-of-1 Trials in Pediatric Oncology: From a Population-Based Approach to Personalized Medicine-A Review.
Cancers (Basel). 2021 Oct 29;13(21):5428. doi: 10.3390/cancers13215428.

本文引用的文献

1
Pharmacogenomics.
Lancet. 2019 Aug 10;394(10197):521-532. doi: 10.1016/S0140-6736(19)31276-0. Epub 2019 Aug 5.
2
Host-dependent variables: The missing link to personalized medicine.
Eur J Surg Oncol. 2018 Sep;44(9):1289-1294. doi: 10.1016/j.ejso.2018.04.014. Epub 2018 Apr 26.
4
Future paradigms for precision oncology.
Oncotarget. 2016 Jul 19;7(29):46813-46831. doi: 10.18632/oncotarget.9488.
5
Determination of the optimal sample size for a clinical trial accounting for the population size.
Biom J. 2017 Jul;59(4):609-625. doi: 10.1002/bimj.201500228. Epub 2016 May 17.
6
Heterogeneity and cancer.
Oncology (Williston Park). 2014 Sep;28(9):772-8.
7
Efficiency of new dose escalation designs in dose-finding phase I trials of molecularly targeted agents.
PLoS One. 2012;7(12):e51039. doi: 10.1371/journal.pone.0051039. Epub 2012 Dec 12.
8
Personal omics profiling reveals dynamic molecular and medical phenotypes.
Cell. 2012 Mar 16;148(6):1293-307. doi: 10.1016/j.cell.2012.02.009.
9
James Lind's Treatise of the Scurvy (1753).
Postgrad Med J. 2002 Nov;78(925):695-6. doi: 10.1136/pmj.78.925.695.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验